Sudation; Fever of 100°F; Cough; Pulmonary pain like pneumonia; Could not raise the arm/affect the movement of the arm; Body aches; Severe headache; Pain at the injection site; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of COVID-19 (Tested positive for Covid-19), PULMONARY PAIN (Pulmonary pain like pneumonia), INJECTED LIMB MOBILITY DECREASED (Could not raise the arm/affect the movement of the arm), HYPERHIDROSIS (Sudation) and COUGH (Cough) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Pneumonia (Reported four years ago). Concurrent medical conditions included Asthma and Lyme disease. Concomitant products included VORTIOXETINE HYDROBROMIDE (TRINTELLIX) for Antidepressant therapy, ASCORBIC ACID (VIT C) and COLECALCIFEROL (VIT D [COLECALCIFEROL]) for an unknown indication.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced INJECTED LIMB MOBILITY DECREASED (Could not raise the arm/affect the movement of the arm), MYALGIA (Body aches), HEADACHE (Severe headache) and VACCINATION SITE PAIN (Pain at the injection site). On 14-Jan-2021, the patient experienced PULMONARY PAIN (Pulmonary pain like pneumonia) and COUGH (Cough). On 18-Jan-2021, the patient experienced COVID-19 (Tested positive for Covid-19). On 19-Jan-2021, the patient experienced HYPERHIDROSIS (Sudation) and PYREXIA (Fever of 100°F). On 14-Jan-2021, PULMONARY PAIN (Pulmonary pain like pneumonia) had resolved. On 19-Jan-2021, HYPERHIDROSIS (Sudation) and PYREXIA (Fever of 100°F) had resolved. On 20-Jan-2021, INJECTED LIMB MOBILITY DECREASED (Could not raise the arm/affect the movement of the arm), COUGH (Cough), MYALGIA (Body aches), HEADACHE (Severe headache) and VACCINATION SITE PAIN (Pain at the injection site) had resolved. At the time of the report, COVID-19 (Tested positive for Covid-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Jan-2021, SARS-CoV-2 antibody test: positive (Positive) Positive. On 19-Jan-2021, Body temperature: 100 (abnormal) 10 degree Fahrenheit.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications included trintellix, vortioxetine hydrobromide, ascorbic acid, and colecalciferol. Treatment medications included isolation, antibiotics, citramax and aspirin.   This case was linked to MOD-2021-013757, MOD-2021-014987, MOD-2021-014992, MOD-2021-015004, MOD-2021-015524, MOD-2021-065849 (E2B Linked Report).; Sender's Comments:  MOD-2021-013757:Same reporter (Patient's husband case) MOD-2021-014987:Same reporter (duplicate case created for same patient, ready for deleteion) MOD-2021-014992:Same reporter (duplicate case created for same patient, ready for deleteion) MOD-2021-015004:Same reporter (Co-worker's case, male patient) MOD-2021-015524:Same reporter (Patient's son case) MOD-2021-065849:Same reporter (Co-worker's wife case, female patient) US-MODERNATX, INC.-MOD-2021-065849:Reporter's female patient case US-MODERNATX, INC.-MOD-2021-015004:Reporter's case, female patient